Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.33B | 1.39B | 1.10B | 656.67M | 418.26M |
Gross Profit | 891.71M | 926.91M | 724.29M | 439.81M | 280.42M |
EBITDA | 186.50M | 320.15M | 294.67M | 93.63M | -350.57M |
Net Income | -37.68M | 167.16M | 113.00K | -248.72M | -628.95M |
Balance Sheet | |||||
Total Assets | 2.29B | 2.27B | 2.15B | 2.11B | 2.33B |
Cash, Cash Equivalents and Short-Term Investments | 83.87M | 36.67M | 34.67M | 26.94M | 16.25M |
Total Debt | 1.84B | 1.90B | 1.93B | 1.84B | 1.90B |
Total Liabilities | 2.33B | 2.31B | 2.36B | 2.33B | 2.31B |
Stockholders Equity | -39.70M | -39.44M | -211.81M | -219.72M | 24.23M |
Cash Flow | |||||
Free Cash Flow | 79.66M | 145.68M | 32.93M | 28.18M | -188.73M |
Operating Cash Flow | 162.01M | 209.13M | 107.15M | 61.00M | -106.31M |
Investing Cash Flow | 69.94M | -72.94M | -55.75M | 40.45M | 26.71M |
Financing Cash Flow | -185.10M | -134.34M | -43.35M | -91.13M | 71.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
61 Neutral | $42.98B | -1.93 | -13.49% | 4.03% | 2.81% | -64.88% | |
55 Neutral | $705.43M | ― | 94.91% | ― | -3.18% | -139.12% | |
― | $13.67M | ― | ― | ― | ― | ||
― | $319.42M | ― | -3581.90% | ― | ― | ― | |
80 Outperform | C$715.11M | 19.76 | 14.14% | 2.85% | 12.00% | ― | |
74 Outperform | C$736.69M | 19.56 | 14.14% | 2.87% | 12.00% | ― | |
69 Neutral | C$580.21M | 6.52 | 10.54% | 6.30% | -0.87% | 9.49% |
Cineplex Inc. announced it will release its second quarter 2025 financial results on August 12, 2025, followed by an earnings webcast hosted by CEO Ellis Jacob and CFO Gord Nelson. This announcement is significant for investors and stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market position and future operations.
The most recent analyst rating on (TSE:CGX) stock is a Buy with a C$12.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex reported strong box office revenues of $51.8 million for June 2025, marking a standout second quarter with revenues exceeding $50 million each month for the first time since 2019. This growth was driven by a robust film slate and high consumer demand for premium formats, with notable performances from films like ‘How to Train Your Dragon’ and ‘F1: The Movie’. Looking forward, Cineplex anticipates continued momentum in Q3 with upcoming releases such as ‘Jurassic World: Rebirth’ and ‘Superman’.
The most recent analyst rating on (TSE:CGX) stock is a Buy with a C$12.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex announced that its long-time President and CEO, Ellis Jacob, will retire at the end of 2026. Jacob will continue to lead the company during the transition to new leadership. His leadership has been instrumental in building Cineplex into a top-tier entertainment company, and his departure marks a significant transition for the company. The board expressed gratitude for his contributions, and Jacob expressed pride in the company’s achievements and confidence in its future.
The most recent analyst rating on (TSE:CGX) stock is a Buy with a C$12.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex reported strong box office revenues of $55.3 million for May 2025, continuing the momentum from a record-breaking April. The success was driven by standout performances from films like Final Destination: Bloodlines, Lilo & Stitch, and Mission: Impossible – the Final Reckoning. The diverse film offerings have bolstered Cineplex’s position in the market, and the company anticipates continued strong performance with upcoming releases in June. This robust performance underscores Cineplex’s strategic positioning to meet sustained demand in the entertainment industry.
The most recent analyst rating on (TSE:CGX) stock is a Buy with a C$12.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex announced that all items of business at its 2025 Annual and Special Meeting of Shareholders were approved, including the election of directors, appointment of auditors, and an increase in shares for its Omnibus Equity Incentive Plan. These approvals reflect shareholder confidence and support for Cineplex’s strategic direction, potentially strengthening its position in the entertainment industry and impacting stakeholders positively.
The most recent analyst rating on (TSE:CGX) stock is a Buy with a C$12.50 price target. To see the full list of analyst forecasts on Cineplex stock, see the TSE:CGX Stock Forecast page.
Cineplex reported its financial results for the first quarter of 2025, showing a decline in total revenues by 10.3% compared to the previous year, with a net loss from continuing operations of $36.6 million. Despite the softer performance in March, the company experienced growth in cinema media and digital media revenues, driven by increased advertising interest and the expansion of its digital out-of-home network. The company is optimistic about future growth due to a strong film slate and the resolution of industry strikes, which is expected to enhance shareholder value.
Cineplex reported its financial results for the first quarter of 2025, highlighting a revenue of $264.3 million despite a softer performance in March. The company entertained 8.4 million moviegoers and achieved a record concession per patron. Notably, cinema advertising saw a 38% increase in media revenues, and digital media revenue grew by 26.5%, driven by an expanded digital out-of-home network. The company also reported a record quarterly location-based entertainment revenue increase of 10.5%. Despite a net loss from continuing operations, Cineplex remains optimistic about future growth, buoyed by a strong film slate and industry momentum.